Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma
暂无分享，去创建一个
F. Lieberman | Y. Shyr | A. Omuro | V. Puduvalli | R. Bindra | D. Shyr | S. Ivy | S. Boerner | M. Pilat | P. Giglio | J. Drappatz | Jing Li | P. LoRusso | Javier Gonzalez | Diane Durecki | Kristina A. Fanucci | Diane E Durecki | D. Durecki